Three dimensional cultivation increases chemo- And radioresistance of colorectal cancer cell lines
PLoS ONE, ISSN: 1932-6203, Vol: 16, Issue: 1 January, Page: e0244513
2021
- 32Citations
- 75Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations32
- Citation Indexes32
- 32
- Captures75
- Readers75
- 75
Article Description
Although 2D cell cultures are commonly used to predict therapy response, it has become clear that 3D cultures may better mimic the in vivo situation and offer the possibility of tailoring translational clinical approaches. Here, we compared the response of 2D and 3D colorectal cancer (CRC) cell lines to irradiation and chemotherapy. Classic 2D cultures and 3D spheroids of CRC cell lines (CaCo2, Colo205, HCT116, SW480) were thoroughly established, then irradiated with doses of 1, 4, or 10 Gy, using a clinical-grade linear accelerator. The response was assessed by immunohistochemistry, flow cytometry, and TUNEL assays. Upon irradiation, CRC 3D spheroids were morphologically altered. After irradiation with 10 Gy, annexin V/PI staining revealed a 1.8- to 4-fold increase in the apoptosis rate in the 2D cell cultures (95% CI 3.24±0.96), and a 1.5- to 2.4-fold increase in the 3D spheroids (95% CI 1.56±0.41). Irradiation with 1 Gy caused 3- and 4-fold increases in TUNEL positive cells in the CaCo2 and HCT116 (p = 0.01) 2D cultures, respectively, compared with a 2-fold increase in the 3D spheroids. Furthermore, the 2D and 3D cultures responded differently to chemotherapy; the 3D cultures were more resistant to 5-FU and cisplatin, but not to doxorubicin and mitomycin C, than the 2D cultures. Taken together, CRC cells cultured as 3D spheroids displayed markedly higher resistance to irradiation therapy and selected chemotherapeutic drugs than 2D cultures. This in vitro difference must be considered in future approaches for determining the ideal in vitro systems that mimic human disease.
Bibliographic Details
10.1371/journal.pone.0244513; 10.1371/journal.pone.0244513.g001; 10.1371/journal.pone.0244513.t001; 10.1371/journal.pone.0244513.g005; 10.1371/journal.pone.0244513.g002; 10.1371/journal.pone.0244513.g003; 10.1371/journal.pone.0244513.g004
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85099331914&origin=inward; http://dx.doi.org/10.1371/journal.pone.0244513; http://www.ncbi.nlm.nih.gov/pubmed/33395433; https://dx.plos.org/10.1371/journal.pone.0244513.g001; http://dx.doi.org/10.1371/journal.pone.0244513.g001; https://dx.plos.org/10.1371/journal.pone.0244513.t001; http://dx.doi.org/10.1371/journal.pone.0244513.t001; https://dx.plos.org/10.1371/journal.pone.0244513.g005; http://dx.doi.org/10.1371/journal.pone.0244513.g005; https://dx.plos.org/10.1371/journal.pone.0244513.g002; http://dx.doi.org/10.1371/journal.pone.0244513.g002; https://dx.plos.org/10.1371/journal.pone.0244513.g003; http://dx.doi.org/10.1371/journal.pone.0244513.g003; https://dx.plos.org/10.1371/journal.pone.0244513.g004; http://dx.doi.org/10.1371/journal.pone.0244513.g004; https://dx.plos.org/10.1371/journal.pone.0244513; https://dx.doi.org/10.1371/journal.pone.0244513; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244513; https://dx.doi.org/10.1371/journal.pone.0244513.g004; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0244513.g004; https://dx.doi.org/10.1371/journal.pone.0244513.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0244513.g002; https://dx.doi.org/10.1371/journal.pone.0244513.g005; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0244513.g005; https://dx.doi.org/10.1371/journal.pone.0244513.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0244513.g001; https://dx.doi.org/10.1371/journal.pone.0244513.t001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0244513.t001; https://dx.doi.org/10.1371/journal.pone.0244513.g003; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0244513.g003; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0244513&type=printable
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know